Tesamorelin 5mg

Tesamorelin 5mg (Research Grade)
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH/GRF) studied for its effects on endogenous growth hormone signalling and related metabolic pathways. FDA prescribing information describes tesamorelin as a human growth hormone-releasing factor analogue, and published research has examined its endocrine and body-composition effects in specific clinical settings.

Research context:
Tesamorelin is not just a generic “research peptide” in the abstract; it is an active pharmaceutical ingredient used in an approved prescription product in the US for a narrow indication, specifically reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. That does not make a loose “5mg research vial” an approved consumer product, and it does not support broad wellness, muscle-building, anti-aging, or fat-loss claims.

Important notice:
For laboratory research use only. Not for human consumption, injection, therapeutic, diagnostic, or veterinary use. Any discussion of mechanism or biological activity is for scientific context only and does not imply safety, efficacy, or approved use for any other purpose. Tesamorelin and related GHRH analogues are also prohibited in sport under anti-doping rules.